Global iPSC-Derived Neural Progenitor Cells Supply, Demand and Key Producers, 2026-2032
The global iPSC-Derived Neural Progenitor Cells market size is expected to reach $ 202 million by 2032, rising at a market growth of 15.2% CAGR during the forecast period (2026-2032).
iPSC-Derived Neural Progenitor Cells (NPCs) are neural stem/progenitor cell products generated from human induced pluripotent stem cells (iPSCs) through directed neural induction. These cells can further differentiate into neurons, astrocytes, and oligodendrocytes. They are typically supplied as cryopreserved cells, cell-plus-media kits, differentiation reagent systems, and customized cell lines. These products are widely used in neurodevelopmental research, disease modeling, drug screening, and early-stage regenerative medicine research. The overall gross margin is approximately 62%.
Demand for iPSC-derived NPCs is primarily driven by applications in neurological disease modeling, developmental neurotoxicity assessment, and high-content drug screening. Compared with primary neural cells, iPSC-derived NPCs offer traceable sourcing, scalable expansion, and customizable donor or genetic backgrounds, enabling broad coverage of research areas such as Alzheimer?s disease, Parkinson?s disease, ALS, autism spectrum disorders, and drug-induced neurotoxicity. As pharmaceutical companies increasingly reduce reliance on animal models and seek more human-relevant early safety assessment tools, demand for standardized NPC products continues to expand in both usage frequency and project scope.
Product development is focused on improving region-specific differentiation stability, disease-specific or gene-edited backgrounds, xeno-free culture systems, and ready-to-use assay formats. Leading suppliers are extending offerings beyond cryopreserved cells to integrated solutions combining cells, culture media, and differentiation protocols, while also developing organoid systems, co-culture models, and high-throughput compatible readouts. However, the market is still constrained by batch-to-batch variability, incomplete maturation control, limited long-term expansion stability, and variability in post-thaw recovery performance. Companies with high-quality cell banks, strict QC standards, and well-validated application datasets are more likely to be adopted by pharmaceutical and CRO customers.
Regionally, North America and Europe remain the primary markets for research and drug screening applications, while China, Japan, and South Korea are increasing investments in iPSC platforms, neurodegenerative disease research, and translational cell therapy programs. In the short term, demand is concentrated in research-grade and screening-grade products. Long-term growth is expected to come from GMP-compatible cell products, preclinical safety validation systems, and support for neuroregenerative therapeutic pipelines.
Report Scope
This report studies the global iPSC-Derived Neural Progenitor Cells production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for iPSC-Derived Neural Progenitor Cells and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of iPSC-Derived Neural Progenitor Cells that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global iPSC-Derived Neural Progenitor Cells total production and demand, 2021-2032, (K Dose)
Global iPSC-Derived Neural Progenitor Cells total production value, 2021-2032, (USD Million)
Global iPSC-Derived Neural Progenitor Cells production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Dose), (based on production site)
Global iPSC-Derived Neural Progenitor Cells consumption by region & country, CAGR, 2021-2032 & (K Dose)
U.S. VS China: iPSC-Derived Neural Progenitor Cells domestic production, consumption, key domestic manufacturers and share
Global iPSC-Derived Neural Progenitor Cells production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Dose)
Global iPSC-Derived Neural Progenitor Cells production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Dose)
Global iPSC-Derived Neural Progenitor Cells production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Dose)
This report profiles key players in the global iPSC-Derived Neural Progenitor Cells market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include STEMCELL Technologies, Merck, Applied StemCell, Axol Bioscience, Tempo Bioscience, Creative Bioarray, ACROBiosystems, ATCC, Cell Applications, AcceGen, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World iPSC-Derived Neural Progenitor Cells market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Dose) and average price (US$/Dose) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global iPSC-Derived Neural Progenitor Cells Market, By Region:
1. How big is the global iPSC-Derived Neural Progenitor Cells market?
2. What is the demand of the global iPSC-Derived Neural Progenitor Cells market?
3. What is the year over year growth of the global iPSC-Derived Neural Progenitor Cells market?
4. What is the production and production value of the global iPSC-Derived Neural Progenitor Cells market?
5. Who are the key producers in the global iPSC-Derived Neural Progenitor Cells market?
6. What are the growth factors driving the market demand?
iPSC-Derived Neural Progenitor Cells (NPCs) are neural stem/progenitor cell products generated from human induced pluripotent stem cells (iPSCs) through directed neural induction. These cells can further differentiate into neurons, astrocytes, and oligodendrocytes. They are typically supplied as cryopreserved cells, cell-plus-media kits, differentiation reagent systems, and customized cell lines. These products are widely used in neurodevelopmental research, disease modeling, drug screening, and early-stage regenerative medicine research. The overall gross margin is approximately 62%.
Demand for iPSC-derived NPCs is primarily driven by applications in neurological disease modeling, developmental neurotoxicity assessment, and high-content drug screening. Compared with primary neural cells, iPSC-derived NPCs offer traceable sourcing, scalable expansion, and customizable donor or genetic backgrounds, enabling broad coverage of research areas such as Alzheimer?s disease, Parkinson?s disease, ALS, autism spectrum disorders, and drug-induced neurotoxicity. As pharmaceutical companies increasingly reduce reliance on animal models and seek more human-relevant early safety assessment tools, demand for standardized NPC products continues to expand in both usage frequency and project scope.
Product development is focused on improving region-specific differentiation stability, disease-specific or gene-edited backgrounds, xeno-free culture systems, and ready-to-use assay formats. Leading suppliers are extending offerings beyond cryopreserved cells to integrated solutions combining cells, culture media, and differentiation protocols, while also developing organoid systems, co-culture models, and high-throughput compatible readouts. However, the market is still constrained by batch-to-batch variability, incomplete maturation control, limited long-term expansion stability, and variability in post-thaw recovery performance. Companies with high-quality cell banks, strict QC standards, and well-validated application datasets are more likely to be adopted by pharmaceutical and CRO customers.
Regionally, North America and Europe remain the primary markets for research and drug screening applications, while China, Japan, and South Korea are increasing investments in iPSC platforms, neurodegenerative disease research, and translational cell therapy programs. In the short term, demand is concentrated in research-grade and screening-grade products. Long-term growth is expected to come from GMP-compatible cell products, preclinical safety validation systems, and support for neuroregenerative therapeutic pipelines.
Report Scope
This report studies the global iPSC-Derived Neural Progenitor Cells production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for iPSC-Derived Neural Progenitor Cells and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of iPSC-Derived Neural Progenitor Cells that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global iPSC-Derived Neural Progenitor Cells total production and demand, 2021-2032, (K Dose)
Global iPSC-Derived Neural Progenitor Cells total production value, 2021-2032, (USD Million)
Global iPSC-Derived Neural Progenitor Cells production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Dose), (based on production site)
Global iPSC-Derived Neural Progenitor Cells consumption by region & country, CAGR, 2021-2032 & (K Dose)
U.S. VS China: iPSC-Derived Neural Progenitor Cells domestic production, consumption, key domestic manufacturers and share
Global iPSC-Derived Neural Progenitor Cells production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Dose)
Global iPSC-Derived Neural Progenitor Cells production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Dose)
Global iPSC-Derived Neural Progenitor Cells production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Dose)
This report profiles key players in the global iPSC-Derived Neural Progenitor Cells market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include STEMCELL Technologies, Merck, Applied StemCell, Axol Bioscience, Tempo Bioscience, Creative Bioarray, ACROBiosystems, ATCC, Cell Applications, AcceGen, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World iPSC-Derived Neural Progenitor Cells market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Dose) and average price (US$/Dose) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global iPSC-Derived Neural Progenitor Cells Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Cryopreserved Cells
- Cell and Media Kits
- Differentiation Kits
- Disease-Specific Cells
- Custom or GMP-Compatible Cells
- Other Formats
- Healthy Control Donor
- Patient-Derived Disease Model
- Gene-Edited Reporter Line
- Immune-Matched or HLA Line
- Custom Donor Background
- Other Donor Background
- Neural Stem Cells
- Neural Progenitor Cells
- Regional Neural Progenitors
- Lineage-Committed Progenitors
- Mature Neural Derivatives
- Other Differentiation Stages
- Research Use Only Grade
- Assay-Ready Grade
- Xeno-Free Defined Grade
- GMP-Compatible Grade
- Custom Validated Grade
- Other Quality Grades
- Neurological Disease Modeling
- Neurotoxicity and Safety Testing
- Drug Screening and Target Validation
- Neural Differentiation and Organoid Culture
- Regenerative Medicine Research
- Other Applications
- STEMCELL Technologies
- Merck
- Applied StemCell
- Axol Bioscience
- Tempo Bioscience
- Creative Bioarray
- ACROBiosystems
- ATCC
- Cell Applications
- AcceGen
1. How big is the global iPSC-Derived Neural Progenitor Cells market?
2. What is the demand of the global iPSC-Derived Neural Progenitor Cells market?
3. What is the year over year growth of the global iPSC-Derived Neural Progenitor Cells market?
4. What is the production and production value of the global iPSC-Derived Neural Progenitor Cells market?
5. Who are the key producers in the global iPSC-Derived Neural Progenitor Cells market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 iPSC-Derived Neural Progenitor Cells Introduction
1.2 World iPSC-Derived Neural Progenitor Cells Supply & Forecast
1.2.1 World iPSC-Derived Neural Progenitor Cells Production Value (2021 & 2025 & 2032)
1.2.2 World iPSC-Derived Neural Progenitor Cells Production (2021-2032)
1.2.3 World iPSC-Derived Neural Progenitor Cells Pricing Trends (2021-2032)
1.3 World iPSC-Derived Neural Progenitor Cells Production by Region (Based on Production Site)
1.3.1 World iPSC-Derived Neural Progenitor Cells Production Value by Region (2021-2032)
1.3.2 World iPSC-Derived Neural Progenitor Cells Production by Region (2021-2032)
1.3.3 World iPSC-Derived Neural Progenitor Cells Average Price by Region (2021-2032)
1.3.4 North America iPSC-Derived Neural Progenitor Cells Production (2021-2032)
1.3.5 Europe iPSC-Derived Neural Progenitor Cells Production (2021-2032)
1.3.6 China iPSC-Derived Neural Progenitor Cells Production (2021-2032)
1.3.7 Japan iPSC-Derived Neural Progenitor Cells Production (2021-2032)
1.3.8 India iPSC-Derived Neural Progenitor Cells Production (2021-2032)
1.3.9 India iPSC-Derived Neural Progenitor Cells Production (2021-2032)
1.3.10 South America iPSC-Derived Neural Progenitor Cells Production (2021-2032)
1.3.11 Middle East iPSC-Derived Neural Progenitor Cells Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 iPSC-Derived Neural Progenitor Cells Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 iPSC-Derived Neural Progenitor Cells Major Market Trends
2 DEMAND SUMMARY
2.1 World iPSC-Derived Neural Progenitor Cells Demand (2021-2032)
2.2 World iPSC-Derived Neural Progenitor Cells Consumption by Region
2.2.1 World iPSC-Derived Neural Progenitor Cells Consumption by Region (2021-2026)
2.2.2 World iPSC-Derived Neural Progenitor Cells Consumption Forecast by Region (2027-2032)
2.3 United States iPSC-Derived Neural Progenitor Cells Consumption (2021-2032)
2.4 China iPSC-Derived Neural Progenitor Cells Consumption (2021-2032)
2.5 Europe iPSC-Derived Neural Progenitor Cells Consumption (2021-2032)
2.6 Japan iPSC-Derived Neural Progenitor Cells Consumption (2021-2032)
2.7 South Korea iPSC-Derived Neural Progenitor Cells Consumption (2021-2032)
2.8 ASEAN iPSC-Derived Neural Progenitor Cells Consumption (2021-2032)
2.9 India iPSC-Derived Neural Progenitor Cells Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World iPSC-Derived Neural Progenitor Cells Production Value by Manufacturer (2021-2026)
3.2 World iPSC-Derived Neural Progenitor Cells Production by Manufacturer (2021-2026)
3.3 World iPSC-Derived Neural Progenitor Cells Average Price by Manufacturer (2021-2026)
3.4 iPSC-Derived Neural Progenitor Cells Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global iPSC-Derived Neural Progenitor Cells Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for iPSC-Derived Neural Progenitor Cells in 2025
3.5.3 Global Concentration Ratios (CR8) for iPSC-Derived Neural Progenitor Cells in 2025
3.6 iPSC-Derived Neural Progenitor Cells Market: Overall Company Footprint Analysis
3.6.1 iPSC-Derived Neural Progenitor Cells Market: Region Footprint
3.6.2 iPSC-Derived Neural Progenitor Cells Market: Company Product Type Footprint
3.6.3 iPSC-Derived Neural Progenitor Cells Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: iPSC-Derived Neural Progenitor Cells Production Value Comparison
4.1.1 United States VS China: iPSC-Derived Neural Progenitor Cells Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: iPSC-Derived Neural Progenitor Cells Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: iPSC-Derived Neural Progenitor Cells Production Comparison
4.2.1 United States VS China: iPSC-Derived Neural Progenitor Cells Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: iPSC-Derived Neural Progenitor Cells Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: iPSC-Derived Neural Progenitor Cells Consumption Comparison
4.3.1 United States VS China: iPSC-Derived Neural Progenitor Cells Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: iPSC-Derived Neural Progenitor Cells Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based iPSC-Derived Neural Progenitor Cells Manufacturers and Market Share, 2021-2026
4.4.1 United States Based iPSC-Derived Neural Progenitor Cells Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers iPSC-Derived Neural Progenitor Cells Production Value (2021-2026)
4.4.3 United States Based Manufacturers iPSC-Derived Neural Progenitor Cells Production (2021-2026)
4.5 China Based iPSC-Derived Neural Progenitor Cells Manufacturers and Market Share
4.5.1 China Based iPSC-Derived Neural Progenitor Cells Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers iPSC-Derived Neural Progenitor Cells Production Value (2021-2026)
4.5.3 China Based Manufacturers iPSC-Derived Neural Progenitor Cells Production (2021-2026)
4.6 Rest of World Based iPSC-Derived Neural Progenitor Cells Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based iPSC-Derived Neural Progenitor Cells Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers iPSC-Derived Neural Progenitor Cells Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers iPSC-Derived Neural Progenitor Cells Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World iPSC-Derived Neural Progenitor Cells Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Cryopreserved Cells
5.2.2 Cell and Media Kits
5.2.3 Differentiation Kits
5.2.4 Disease-Specific Cells
5.2.5 Custom or GMP-Compatible Cells
5.2.6 Other Formats
5.3 Market Segment by Type
5.3.1 World iPSC-Derived Neural Progenitor Cells Production by Type (2021-2032)
5.3.2 World iPSC-Derived Neural Progenitor Cells Production Value by Type (2021-2032)
5.3.3 World iPSC-Derived Neural Progenitor Cells Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY DONOR OR DISEASE BACKGROUND
6.1 World iPSC-Derived Neural Progenitor Cells Market Size Overview by Donor or Disease Background: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Donor or Disease Background
6.2.1 Healthy Control Donor
6.2.2 Patient-Derived Disease Model
6.2.3 Gene-Edited Reporter Line
6.2.4 Immune-Matched or HLA Line
6.2.5 Custom Donor Background
6.2.6 Other Donor Background
6.3 Market Segment by Donor or Disease Background
6.3.1 World iPSC-Derived Neural Progenitor Cells Production by Donor or Disease Background (2021-2032)
6.3.2 World iPSC-Derived Neural Progenitor Cells Production Value by Donor or Disease Background (2021-2032)
6.3.3 World iPSC-Derived Neural Progenitor Cells Average Price by Donor or Disease Background (2021-2032)
7 MARKET ANALYSIS BY DIFFERENTIATION STAGE
7.1 World iPSC-Derived Neural Progenitor Cells Market Size Overview by Differentiation Stage: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Differentiation Stage
7.2.1 Neural Stem Cells
7.2.2 Neural Progenitor Cells
7.2.3 Regional Neural Progenitors
7.2.4 Lineage-Committed Progenitors
7.2.5 Mature Neural Derivatives
7.2.6 Other Differentiation Stages
7.3 Market Segment by Differentiation Stage
7.3.1 World iPSC-Derived Neural Progenitor Cells Production by Differentiation Stage (2021-2032)
7.3.2 World iPSC-Derived Neural Progenitor Cells Production Value by Differentiation Stage (2021-2032)
7.3.3 World iPSC-Derived Neural Progenitor Cells Average Price by Differentiation Stage (2021-2032)
8 MARKET ANALYSIS BY QUALITY GRADE
8.1 World iPSC-Derived Neural Progenitor Cells Market Size Overview by Quality Grade: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Quality Grade
8.2.1 Research Use Only Grade
8.2.2 Assay-Ready Grade
8.2.3 Xeno-Free Defined Grade
8.2.4 GMP-Compatible Grade
8.2.5 Custom Validated Grade
8.2.6 Other Quality Grades
8.3 Market Segment by Quality Grade
8.3.1 World iPSC-Derived Neural Progenitor Cells Production by Quality Grade (2021-2032)
8.3.2 World iPSC-Derived Neural Progenitor Cells Production Value by Quality Grade (2021-2032)
8.3.3 World iPSC-Derived Neural Progenitor Cells Average Price by Quality Grade (2021-2032)
9 MARKET ANALYSIS BY APPLICATION
9.1 World iPSC-Derived Neural Progenitor Cells Market Size Overview by Application: 2021 VS 2025 VS 2032
9.2 Segment Introduction by Application
9.2.1 Neurological Disease Modeling
9.2.2 Neurotoxicity and Safety Testing
9.2.3 Drug Screening and Target Validation
9.2.4 Neural Differentiation and Organoid Culture
9.2.5 Regenerative Medicine Research
9.2.6 Other Applications
9.3 Market Segment by Application
9.3.1 World iPSC-Derived Neural Progenitor Cells Production by Application (2021-2032)
9.3.2 World iPSC-Derived Neural Progenitor Cells Production Value by Application (2021-2032)
9.3.3 World iPSC-Derived Neural Progenitor Cells Average Price by Application (2021-2032)
10 COMPANY PROFILES
10.1 STEMCELL Technologies
10.1.1 STEMCELL Technologies Details
10.1.2 STEMCELL Technologies Major Business
10.1.3 STEMCELL Technologies iPSC-Derived Neural Progenitor Cells Product and Services
10.1.4 STEMCELL Technologies iPSC-Derived Neural Progenitor Cells Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.1.5 STEMCELL Technologies Recent Developments/Updates
10.1.6 STEMCELL Technologies Competitive Strengths & Weaknesses
10.2 Merck
10.2.1 Merck Details
10.2.2 Merck Major Business
10.2.3 Merck iPSC-Derived Neural Progenitor Cells Product and Services
10.2.4 Merck iPSC-Derived Neural Progenitor Cells Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.2.5 Merck Recent Developments/Updates
10.2.6 Merck Competitive Strengths & Weaknesses
10.3 Applied StemCell
10.3.1 Applied StemCell Details
10.3.2 Applied StemCell Major Business
10.3.3 Applied StemCell iPSC-Derived Neural Progenitor Cells Product and Services
10.3.4 Applied StemCell iPSC-Derived Neural Progenitor Cells Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.3.5 Applied StemCell Recent Developments/Updates
10.3.6 Applied StemCell Competitive Strengths & Weaknesses
10.4 Axol Bioscience
10.4.1 Axol Bioscience Details
10.4.2 Axol Bioscience Major Business
10.4.3 Axol Bioscience iPSC-Derived Neural Progenitor Cells Product and Services
10.4.4 Axol Bioscience iPSC-Derived Neural Progenitor Cells Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.4.5 Axol Bioscience Recent Developments/Updates
10.4.6 Axol Bioscience Competitive Strengths & Weaknesses
10.5 Tempo Bioscience
10.5.1 Tempo Bioscience Details
10.5.2 Tempo Bioscience Major Business
10.5.3 Tempo Bioscience iPSC-Derived Neural Progenitor Cells Product and Services
10.5.4 Tempo Bioscience iPSC-Derived Neural Progenitor Cells Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.5.5 Tempo Bioscience Recent Developments/Updates
10.5.6 Tempo Bioscience Competitive Strengths & Weaknesses
10.6 Creative Bioarray
10.6.1 Creative Bioarray Details
10.6.2 Creative Bioarray Major Business
10.6.3 Creative Bioarray iPSC-Derived Neural Progenitor Cells Product and Services
10.6.4 Creative Bioarray iPSC-Derived Neural Progenitor Cells Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.6.5 Creative Bioarray Recent Developments/Updates
10.6.6 Creative Bioarray Competitive Strengths & Weaknesses
10.7 ACROBiosystems
10.7.1 ACROBiosystems Details
10.7.2 ACROBiosystems Major Business
10.7.3 ACROBiosystems iPSC-Derived Neural Progenitor Cells Product and Services
10.7.4 ACROBiosystems iPSC-Derived Neural Progenitor Cells Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.7.5 ACROBiosystems Recent Developments/Updates
10.7.6 ACROBiosystems Competitive Strengths & Weaknesses
10.8 ATCC
10.8.1 ATCC Details
10.8.2 ATCC Major Business
10.8.3 ATCC iPSC-Derived Neural Progenitor Cells Product and Services
10.8.4 ATCC iPSC-Derived Neural Progenitor Cells Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.8.5 ATCC Recent Developments/Updates
10.8.6 ATCC Competitive Strengths & Weaknesses
10.9 Cell Applications
10.9.1 Cell Applications Details
10.9.2 Cell Applications Major Business
10.9.3 Cell Applications iPSC-Derived Neural Progenitor Cells Product and Services
10.9.4 Cell Applications iPSC-Derived Neural Progenitor Cells Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.9.5 Cell Applications Recent Developments/Updates
10.9.6 Cell Applications Competitive Strengths & Weaknesses
10.10 AcceGen
10.10.1 AcceGen Details
10.10.2 AcceGen Major Business
10.10.3 AcceGen iPSC-Derived Neural Progenitor Cells Product and Services
10.10.4 AcceGen iPSC-Derived Neural Progenitor Cells Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.10.5 AcceGen Recent Developments/Updates
10.10.6 AcceGen Competitive Strengths & Weaknesses
11 INDUSTRY CHAIN ANALYSIS
11.1 iPSC-Derived Neural Progenitor Cells Industry Chain
11.2 iPSC-Derived Neural Progenitor Cells Upstream Analysis
11.2.1 iPSC-Derived Neural Progenitor Cells Core Raw Materials
11.2.2 Main Manufacturers of iPSC-Derived Neural Progenitor Cells Core Raw Materials
11.3 Midstream Analysis
11.4 Downstream Analysis
11.5 iPSC-Derived Neural Progenitor Cells Production Mode
11.6 iPSC-Derived Neural Progenitor Cells Procurement Model
11.7 iPSC-Derived Neural Progenitor Cells Industry Sales Model and Sales Channels
11.7.1 iPSC-Derived Neural Progenitor Cells Sales Model
11.7.2 iPSC-Derived Neural Progenitor Cells Typical Distributors
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology
13.2 Research Process and Data Source
13.3 Disclaimer
1.1 iPSC-Derived Neural Progenitor Cells Introduction
1.2 World iPSC-Derived Neural Progenitor Cells Supply & Forecast
1.2.1 World iPSC-Derived Neural Progenitor Cells Production Value (2021 & 2025 & 2032)
1.2.2 World iPSC-Derived Neural Progenitor Cells Production (2021-2032)
1.2.3 World iPSC-Derived Neural Progenitor Cells Pricing Trends (2021-2032)
1.3 World iPSC-Derived Neural Progenitor Cells Production by Region (Based on Production Site)
1.3.1 World iPSC-Derived Neural Progenitor Cells Production Value by Region (2021-2032)
1.3.2 World iPSC-Derived Neural Progenitor Cells Production by Region (2021-2032)
1.3.3 World iPSC-Derived Neural Progenitor Cells Average Price by Region (2021-2032)
1.3.4 North America iPSC-Derived Neural Progenitor Cells Production (2021-2032)
1.3.5 Europe iPSC-Derived Neural Progenitor Cells Production (2021-2032)
1.3.6 China iPSC-Derived Neural Progenitor Cells Production (2021-2032)
1.3.7 Japan iPSC-Derived Neural Progenitor Cells Production (2021-2032)
1.3.8 India iPSC-Derived Neural Progenitor Cells Production (2021-2032)
1.3.9 India iPSC-Derived Neural Progenitor Cells Production (2021-2032)
1.3.10 South America iPSC-Derived Neural Progenitor Cells Production (2021-2032)
1.3.11 Middle East iPSC-Derived Neural Progenitor Cells Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 iPSC-Derived Neural Progenitor Cells Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 iPSC-Derived Neural Progenitor Cells Major Market Trends
2 DEMAND SUMMARY
2.1 World iPSC-Derived Neural Progenitor Cells Demand (2021-2032)
2.2 World iPSC-Derived Neural Progenitor Cells Consumption by Region
2.2.1 World iPSC-Derived Neural Progenitor Cells Consumption by Region (2021-2026)
2.2.2 World iPSC-Derived Neural Progenitor Cells Consumption Forecast by Region (2027-2032)
2.3 United States iPSC-Derived Neural Progenitor Cells Consumption (2021-2032)
2.4 China iPSC-Derived Neural Progenitor Cells Consumption (2021-2032)
2.5 Europe iPSC-Derived Neural Progenitor Cells Consumption (2021-2032)
2.6 Japan iPSC-Derived Neural Progenitor Cells Consumption (2021-2032)
2.7 South Korea iPSC-Derived Neural Progenitor Cells Consumption (2021-2032)
2.8 ASEAN iPSC-Derived Neural Progenitor Cells Consumption (2021-2032)
2.9 India iPSC-Derived Neural Progenitor Cells Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World iPSC-Derived Neural Progenitor Cells Production Value by Manufacturer (2021-2026)
3.2 World iPSC-Derived Neural Progenitor Cells Production by Manufacturer (2021-2026)
3.3 World iPSC-Derived Neural Progenitor Cells Average Price by Manufacturer (2021-2026)
3.4 iPSC-Derived Neural Progenitor Cells Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global iPSC-Derived Neural Progenitor Cells Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for iPSC-Derived Neural Progenitor Cells in 2025
3.5.3 Global Concentration Ratios (CR8) for iPSC-Derived Neural Progenitor Cells in 2025
3.6 iPSC-Derived Neural Progenitor Cells Market: Overall Company Footprint Analysis
3.6.1 iPSC-Derived Neural Progenitor Cells Market: Region Footprint
3.6.2 iPSC-Derived Neural Progenitor Cells Market: Company Product Type Footprint
3.6.3 iPSC-Derived Neural Progenitor Cells Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: iPSC-Derived Neural Progenitor Cells Production Value Comparison
4.1.1 United States VS China: iPSC-Derived Neural Progenitor Cells Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: iPSC-Derived Neural Progenitor Cells Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: iPSC-Derived Neural Progenitor Cells Production Comparison
4.2.1 United States VS China: iPSC-Derived Neural Progenitor Cells Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: iPSC-Derived Neural Progenitor Cells Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: iPSC-Derived Neural Progenitor Cells Consumption Comparison
4.3.1 United States VS China: iPSC-Derived Neural Progenitor Cells Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: iPSC-Derived Neural Progenitor Cells Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based iPSC-Derived Neural Progenitor Cells Manufacturers and Market Share, 2021-2026
4.4.1 United States Based iPSC-Derived Neural Progenitor Cells Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers iPSC-Derived Neural Progenitor Cells Production Value (2021-2026)
4.4.3 United States Based Manufacturers iPSC-Derived Neural Progenitor Cells Production (2021-2026)
4.5 China Based iPSC-Derived Neural Progenitor Cells Manufacturers and Market Share
4.5.1 China Based iPSC-Derived Neural Progenitor Cells Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers iPSC-Derived Neural Progenitor Cells Production Value (2021-2026)
4.5.3 China Based Manufacturers iPSC-Derived Neural Progenitor Cells Production (2021-2026)
4.6 Rest of World Based iPSC-Derived Neural Progenitor Cells Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based iPSC-Derived Neural Progenitor Cells Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers iPSC-Derived Neural Progenitor Cells Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers iPSC-Derived Neural Progenitor Cells Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World iPSC-Derived Neural Progenitor Cells Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Cryopreserved Cells
5.2.2 Cell and Media Kits
5.2.3 Differentiation Kits
5.2.4 Disease-Specific Cells
5.2.5 Custom or GMP-Compatible Cells
5.2.6 Other Formats
5.3 Market Segment by Type
5.3.1 World iPSC-Derived Neural Progenitor Cells Production by Type (2021-2032)
5.3.2 World iPSC-Derived Neural Progenitor Cells Production Value by Type (2021-2032)
5.3.3 World iPSC-Derived Neural Progenitor Cells Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY DONOR OR DISEASE BACKGROUND
6.1 World iPSC-Derived Neural Progenitor Cells Market Size Overview by Donor or Disease Background: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Donor or Disease Background
6.2.1 Healthy Control Donor
6.2.2 Patient-Derived Disease Model
6.2.3 Gene-Edited Reporter Line
6.2.4 Immune-Matched or HLA Line
6.2.5 Custom Donor Background
6.2.6 Other Donor Background
6.3 Market Segment by Donor or Disease Background
6.3.1 World iPSC-Derived Neural Progenitor Cells Production by Donor or Disease Background (2021-2032)
6.3.2 World iPSC-Derived Neural Progenitor Cells Production Value by Donor or Disease Background (2021-2032)
6.3.3 World iPSC-Derived Neural Progenitor Cells Average Price by Donor or Disease Background (2021-2032)
7 MARKET ANALYSIS BY DIFFERENTIATION STAGE
7.1 World iPSC-Derived Neural Progenitor Cells Market Size Overview by Differentiation Stage: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Differentiation Stage
7.2.1 Neural Stem Cells
7.2.2 Neural Progenitor Cells
7.2.3 Regional Neural Progenitors
7.2.4 Lineage-Committed Progenitors
7.2.5 Mature Neural Derivatives
7.2.6 Other Differentiation Stages
7.3 Market Segment by Differentiation Stage
7.3.1 World iPSC-Derived Neural Progenitor Cells Production by Differentiation Stage (2021-2032)
7.3.2 World iPSC-Derived Neural Progenitor Cells Production Value by Differentiation Stage (2021-2032)
7.3.3 World iPSC-Derived Neural Progenitor Cells Average Price by Differentiation Stage (2021-2032)
8 MARKET ANALYSIS BY QUALITY GRADE
8.1 World iPSC-Derived Neural Progenitor Cells Market Size Overview by Quality Grade: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Quality Grade
8.2.1 Research Use Only Grade
8.2.2 Assay-Ready Grade
8.2.3 Xeno-Free Defined Grade
8.2.4 GMP-Compatible Grade
8.2.5 Custom Validated Grade
8.2.6 Other Quality Grades
8.3 Market Segment by Quality Grade
8.3.1 World iPSC-Derived Neural Progenitor Cells Production by Quality Grade (2021-2032)
8.3.2 World iPSC-Derived Neural Progenitor Cells Production Value by Quality Grade (2021-2032)
8.3.3 World iPSC-Derived Neural Progenitor Cells Average Price by Quality Grade (2021-2032)
9 MARKET ANALYSIS BY APPLICATION
9.1 World iPSC-Derived Neural Progenitor Cells Market Size Overview by Application: 2021 VS 2025 VS 2032
9.2 Segment Introduction by Application
9.2.1 Neurological Disease Modeling
9.2.2 Neurotoxicity and Safety Testing
9.2.3 Drug Screening and Target Validation
9.2.4 Neural Differentiation and Organoid Culture
9.2.5 Regenerative Medicine Research
9.2.6 Other Applications
9.3 Market Segment by Application
9.3.1 World iPSC-Derived Neural Progenitor Cells Production by Application (2021-2032)
9.3.2 World iPSC-Derived Neural Progenitor Cells Production Value by Application (2021-2032)
9.3.3 World iPSC-Derived Neural Progenitor Cells Average Price by Application (2021-2032)
10 COMPANY PROFILES
10.1 STEMCELL Technologies
10.1.1 STEMCELL Technologies Details
10.1.2 STEMCELL Technologies Major Business
10.1.3 STEMCELL Technologies iPSC-Derived Neural Progenitor Cells Product and Services
10.1.4 STEMCELL Technologies iPSC-Derived Neural Progenitor Cells Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.1.5 STEMCELL Technologies Recent Developments/Updates
10.1.6 STEMCELL Technologies Competitive Strengths & Weaknesses
10.2 Merck
10.2.1 Merck Details
10.2.2 Merck Major Business
10.2.3 Merck iPSC-Derived Neural Progenitor Cells Product and Services
10.2.4 Merck iPSC-Derived Neural Progenitor Cells Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.2.5 Merck Recent Developments/Updates
10.2.6 Merck Competitive Strengths & Weaknesses
10.3 Applied StemCell
10.3.1 Applied StemCell Details
10.3.2 Applied StemCell Major Business
10.3.3 Applied StemCell iPSC-Derived Neural Progenitor Cells Product and Services
10.3.4 Applied StemCell iPSC-Derived Neural Progenitor Cells Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.3.5 Applied StemCell Recent Developments/Updates
10.3.6 Applied StemCell Competitive Strengths & Weaknesses
10.4 Axol Bioscience
10.4.1 Axol Bioscience Details
10.4.2 Axol Bioscience Major Business
10.4.3 Axol Bioscience iPSC-Derived Neural Progenitor Cells Product and Services
10.4.4 Axol Bioscience iPSC-Derived Neural Progenitor Cells Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.4.5 Axol Bioscience Recent Developments/Updates
10.4.6 Axol Bioscience Competitive Strengths & Weaknesses
10.5 Tempo Bioscience
10.5.1 Tempo Bioscience Details
10.5.2 Tempo Bioscience Major Business
10.5.3 Tempo Bioscience iPSC-Derived Neural Progenitor Cells Product and Services
10.5.4 Tempo Bioscience iPSC-Derived Neural Progenitor Cells Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.5.5 Tempo Bioscience Recent Developments/Updates
10.5.6 Tempo Bioscience Competitive Strengths & Weaknesses
10.6 Creative Bioarray
10.6.1 Creative Bioarray Details
10.6.2 Creative Bioarray Major Business
10.6.3 Creative Bioarray iPSC-Derived Neural Progenitor Cells Product and Services
10.6.4 Creative Bioarray iPSC-Derived Neural Progenitor Cells Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.6.5 Creative Bioarray Recent Developments/Updates
10.6.6 Creative Bioarray Competitive Strengths & Weaknesses
10.7 ACROBiosystems
10.7.1 ACROBiosystems Details
10.7.2 ACROBiosystems Major Business
10.7.3 ACROBiosystems iPSC-Derived Neural Progenitor Cells Product and Services
10.7.4 ACROBiosystems iPSC-Derived Neural Progenitor Cells Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.7.5 ACROBiosystems Recent Developments/Updates
10.7.6 ACROBiosystems Competitive Strengths & Weaknesses
10.8 ATCC
10.8.1 ATCC Details
10.8.2 ATCC Major Business
10.8.3 ATCC iPSC-Derived Neural Progenitor Cells Product and Services
10.8.4 ATCC iPSC-Derived Neural Progenitor Cells Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.8.5 ATCC Recent Developments/Updates
10.8.6 ATCC Competitive Strengths & Weaknesses
10.9 Cell Applications
10.9.1 Cell Applications Details
10.9.2 Cell Applications Major Business
10.9.3 Cell Applications iPSC-Derived Neural Progenitor Cells Product and Services
10.9.4 Cell Applications iPSC-Derived Neural Progenitor Cells Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.9.5 Cell Applications Recent Developments/Updates
10.9.6 Cell Applications Competitive Strengths & Weaknesses
10.10 AcceGen
10.10.1 AcceGen Details
10.10.2 AcceGen Major Business
10.10.3 AcceGen iPSC-Derived Neural Progenitor Cells Product and Services
10.10.4 AcceGen iPSC-Derived Neural Progenitor Cells Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.10.5 AcceGen Recent Developments/Updates
10.10.6 AcceGen Competitive Strengths & Weaknesses
11 INDUSTRY CHAIN ANALYSIS
11.1 iPSC-Derived Neural Progenitor Cells Industry Chain
11.2 iPSC-Derived Neural Progenitor Cells Upstream Analysis
11.2.1 iPSC-Derived Neural Progenitor Cells Core Raw Materials
11.2.2 Main Manufacturers of iPSC-Derived Neural Progenitor Cells Core Raw Materials
11.3 Midstream Analysis
11.4 Downstream Analysis
11.5 iPSC-Derived Neural Progenitor Cells Production Mode
11.6 iPSC-Derived Neural Progenitor Cells Procurement Model
11.7 iPSC-Derived Neural Progenitor Cells Industry Sales Model and Sales Channels
11.7.1 iPSC-Derived Neural Progenitor Cells Sales Model
11.7.2 iPSC-Derived Neural Progenitor Cells Typical Distributors
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology
13.2 Research Process and Data Source
13.3 Disclaimer
LIST OF TABLES
Table 1. World iPSC-Derived Neural Progenitor Cells Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World iPSC-Derived Neural Progenitor Cells Production Value by Region (2021-2026) & (USD Million)
Table 3. World iPSC-Derived Neural Progenitor Cells Production Value by Region (2027-2032) & (USD Million)
Table 4. World iPSC-Derived Neural Progenitor Cells Production Value Market Share by Region (2021-2026)
Table 5. World iPSC-Derived Neural Progenitor Cells Production Value Market Share by Region (2027-2032)
Table 6. World iPSC-Derived Neural Progenitor Cells Production by Region (2021-2026) & (K Dose)
Table 7. World iPSC-Derived Neural Progenitor Cells Production by Region (2027-2032) & (K Dose)
Table 8. World iPSC-Derived Neural Progenitor Cells Production Market Share by Region (2021-2026)
Table 9. World iPSC-Derived Neural Progenitor Cells Production Market Share by Region (2027-2032)
Table 10. World iPSC-Derived Neural Progenitor Cells Average Price by Region (2021-2026) & (US$/Dose)
Table 11. World iPSC-Derived Neural Progenitor Cells Average Price by Region (2027-2032) & (US$/Dose)
Table 12. iPSC-Derived Neural Progenitor Cells Major Market Trends
Table 13. World iPSC-Derived Neural Progenitor Cells Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Dose)
Table 14. World iPSC-Derived Neural Progenitor Cells Consumption by Region (2021-2026) & (K Dose)
Table 15. World iPSC-Derived Neural Progenitor Cells Consumption Forecast by Region (2027-2032) & (K Dose)
Table 16. World iPSC-Derived Neural Progenitor Cells Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key iPSC-Derived Neural Progenitor Cells Producers in 2025
Table 18. World iPSC-Derived Neural Progenitor Cells Production by Manufacturer (2021-2026) & (K Dose)
Table 19. Production Market Share of Key iPSC-Derived Neural Progenitor Cells Producers in 2025
Table 20. World iPSC-Derived Neural Progenitor Cells Average Price by Manufacturer (2021-2026) & (US$/Dose)
Table 21. Global iPSC-Derived Neural Progenitor Cells Company Evaluation Quadrant
Table 22. World iPSC-Derived Neural Progenitor Cells Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and iPSC-Derived Neural Progenitor Cells Production Site of Key Manufacturer
Table 24. iPSC-Derived Neural Progenitor Cells Market: Company Product Type Footprint
Table 25. iPSC-Derived Neural Progenitor Cells Market: Company Product Application Footprint
Table 26. iPSC-Derived Neural Progenitor Cells Competitive Factors
Table 27. iPSC-Derived Neural Progenitor Cells New Entrant and Capacity Expansion Plans
Table 28. iPSC-Derived Neural Progenitor Cells Mergers & Acquisitions Activity
Table 29. United States VS China iPSC-Derived Neural Progenitor Cells Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China iPSC-Derived Neural Progenitor Cells Production Comparison, (2021 & 2025 & 2032) & (K Dose)
Table 31. United States VS China iPSC-Derived Neural Progenitor Cells Consumption Comparison, (2021 & 2025 & 2032) & (K Dose)
Table 32. United States Based iPSC-Derived Neural Progenitor Cells Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers iPSC-Derived Neural Progenitor Cells Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers iPSC-Derived Neural Progenitor Cells Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers iPSC-Derived Neural Progenitor Cells Production (2021-2026) & (K Dose)
Table 36. United States Based Manufacturers iPSC-Derived Neural Progenitor Cells Production Market Share (2021-2026)
Table 37. China Based iPSC-Derived Neural Progenitor Cells Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers iPSC-Derived Neural Progenitor Cells Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers iPSC-Derived Neural Progenitor Cells Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers iPSC-Derived Neural Progenitor Cells Production, (2021-2026) & (K Dose)
Table 41. China Based Manufacturers iPSC-Derived Neural Progenitor Cells Production Market Share (2021-2026)
Table 42. Rest of World Based iPSC-Derived Neural Progenitor Cells Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers iPSC-Derived Neural Progenitor Cells Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers iPSC-Derived Neural Progenitor Cells Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers iPSC-Derived Neural Progenitor Cells Production, (2021-2026) & (K Dose)
Table 46. Rest of World Based Manufacturers iPSC-Derived Neural Progenitor Cells Production Market Share (2021-2026)
Table 47. World iPSC-Derived Neural Progenitor Cells Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World iPSC-Derived Neural Progenitor Cells Production by Type (2021-2026) & (K Dose)
Table 49. World iPSC-Derived Neural Progenitor Cells Production by Type (2027-2032) & (K Dose)
Table 50. World iPSC-Derived Neural Progenitor Cells Production Value by Type (2021-2026) & (USD Million)
Table 51. World iPSC-Derived Neural Progenitor Cells Production Value by Type (2027-2032) & (USD Million)
Table 52. World iPSC-Derived Neural Progenitor Cells Average Price by Type (2021-2026) & (US$/Dose)
Table 53. World iPSC-Derived Neural Progenitor Cells Average Price by Type (2027-2032) & (US$/Dose)
Table 54. World iPSC-Derived Neural Progenitor Cells Production Value by Donor or Disease Background, (USD Million), 2021 & 2025 & 2032
Table 55. World iPSC-Derived Neural Progenitor Cells Production by Donor or Disease Background (2021-2026) & (K Dose)
Table 56. World iPSC-Derived Neural Progenitor Cells Production by Donor or Disease Background (2027-2032) & (K Dose)
Table 57. World iPSC-Derived Neural Progenitor Cells Production Value by Donor or Disease Background (2021-2026) & (USD Million)
Table 58. World iPSC-Derived Neural Progenitor Cells Production Value by Donor or Disease Background (2027-2032) & (USD Million)
Table 59. World iPSC-Derived Neural Progenitor Cells Average Price by Donor or Disease Background (2021-2026) & (US$/Dose)
Table 60. World iPSC-Derived Neural Progenitor Cells Average Price by Donor or Disease Background (2027-2032) & (US$/Dose)
Table 61. World iPSC-Derived Neural Progenitor Cells Production Value by Differentiation Stage, (USD Million), 2021 & 2025 & 2032
Table 62. World iPSC-Derived Neural Progenitor Cells Production by Differentiation Stage (2021-2026) & (K Dose)
Table 63. World iPSC-Derived Neural Progenitor Cells Production by Differentiation Stage (2027-2032) & (K Dose)
Table 64. World iPSC-Derived Neural Progenitor Cells Production Value by Differentiation Stage (2021-2026) & (USD Million)
Table 65. World iPSC-Derived Neural Progenitor Cells Production Value by Differentiation Stage (2027-2032) & (USD Million)
Table 66. World iPSC-Derived Neural Progenitor Cells Average Price by Differentiation Stage (2021-2026) & (US$/Dose)
Table 67. World iPSC-Derived Neural Progenitor Cells Average Price by Differentiation Stage (2027-2032) & (US$/Dose)
Table 68. World iPSC-Derived Neural Progenitor Cells Production Value by Quality Grade, (USD Million), 2021 & 2025 & 2032
Table 69. World iPSC-Derived Neural Progenitor Cells Production by Quality Grade (2021-2026) & (K Dose)
Table 70. World iPSC-Derived Neural Progenitor Cells Production by Quality Grade (2027-2032) & (K Dose)
Table 71. World iPSC-Derived Neural Progenitor Cells Production Value by Quality Grade (2021-2026) & (USD Million)
Table 72. World iPSC-Derived Neural Progenitor Cells Production Value by Quality Grade (2027-2032) & (USD Million)
Table 73. World iPSC-Derived Neural Progenitor Cells Average Price by Quality Grade (2021-2026) & (US$/Dose)
Table 74. World iPSC-Derived Neural Progenitor Cells Average Price by Quality Grade (2027-2032) & (US$/Dose)
Table 75. World iPSC-Derived Neural Progenitor Cells Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 76. World iPSC-Derived Neural Progenitor Cells Production by Application (2021-2026) & (K Dose)
Table 77. World iPSC-Derived Neural Progenitor Cells Production by Application (2027-2032) & (K Dose)
Table 78. World iPSC-Derived Neural Progenitor Cells Production Value by Application (2021-2026) & (USD Million)
Table 79. World iPSC-Derived Neural Progenitor Cells Production Value by Application (2027-2032) & (USD Million)
Table 80. World iPSC-Derived Neural Progenitor Cells Average Price by Application (2021-2026) & (US$/Dose)
Table 81. World iPSC-Derived Neural Progenitor Cells Average Price by Application (2027-2032) & (US$/Dose)
Table 82. STEMCELL Technologies Basic Information, Manufacturing Base and Competitors
Table 83. STEMCELL Technologies Major Business
Table 84. STEMCELL Technologies iPSC-Derived Neural Progenitor Cells Product and Services
Table 85. STEMCELL Technologies iPSC-Derived Neural Progenitor Cells Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 86. STEMCELL Technologies Recent Developments/Updates
Table 87. STEMCELL Technologies Competitive Strengths & Weaknesses
Table 88. Merck Basic Information, Manufacturing Base and Competitors
Table 89. Merck Major Business
Table 90. Merck iPSC-Derived Neural Progenitor Cells Product and Services
Table 91. Merck iPSC-Derived Neural Progenitor Cells Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 92. Merck Recent Developments/Updates
Table 93. Merck Competitive Strengths & Weaknesses
Table 94. Applied StemCell Basic Information, Manufacturing Base and Competitors
Table 95. Applied StemCell Major Business
Table 96. Applied StemCell iPSC-Derived Neural Progenitor Cells Product and Services
Table 97. Applied StemCell iPSC-Derived Neural Progenitor Cells Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 98. Applied StemCell Recent Developments/Updates
Table 99. Applied StemCell Competitive Strengths & Weaknesses
Table 100. Axol Bioscience Basic Information, Manufacturing Base and Competitors
Table 101. Axol Bioscience Major Business
Table 102. Axol Bioscience iPSC-Derived Neural Progenitor Cells Product and Services
Table 103. Axol Bioscience iPSC-Derived Neural Progenitor Cells Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 104. Axol Bioscience Recent Developments/Updates
Table 105. Axol Bioscience Competitive Strengths & Weaknesses
Table 106. Tempo Bioscience Basic Information, Manufacturing Base and Competitors
Table 107. Tempo Bioscience Major Business
Table 108. Tempo Bioscience iPSC-Derived Neural Progenitor Cells Product and Services
Table 109. Tempo Bioscience iPSC-Derived Neural Progenitor Cells Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 110. Tempo Bioscience Recent Developments/Updates
Table 111. Tempo Bioscience Competitive Strengths & Weaknesses
Table 112. Creative Bioarray Basic Information, Manufacturing Base and Competitors
Table 113. Creative Bioarray Major Business
Table 114. Creative Bioarray iPSC-Derived Neural Progenitor Cells Product and Services
Table 115. Creative Bioarray iPSC-Derived Neural Progenitor Cells Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 116. Creative Bioarray Recent Developments/Updates
Table 117. Creative Bioarray Competitive Strengths & Weaknesses
Table 118. ACROBiosystems Basic Information, Manufacturing Base and Competitors
Table 119. ACROBiosystems Major Business
Table 120. ACROBiosystems iPSC-Derived Neural Progenitor Cells Product and Services
Table 121. ACROBiosystems iPSC-Derived Neural Progenitor Cells Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 122. ACROBiosystems Recent Developments/Updates
Table 123. ACROBiosystems Competitive Strengths & Weaknesses
Table 124. ATCC Basic Information, Manufacturing Base and Competitors
Table 125. ATCC Major Business
Table 126. ATCC iPSC-Derived Neural Progenitor Cells Product and Services
Table 127. ATCC iPSC-Derived Neural Progenitor Cells Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 128. ATCC Recent Developments/Updates
Table 129. ATCC Competitive Strengths & Weaknesses
Table 130. Cell Applications Basic Information, Manufacturing Base and Competitors
Table 131. Cell Applications Major Business
Table 132. Cell Applications iPSC-Derived Neural Progenitor Cells Product and Services
Table 133. Cell Applications iPSC-Derived Neural Progenitor Cells Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 134. Cell Applications Recent Developments/Updates
Table 135. Cell Applications Competitive Strengths & Weaknesses
Table 136. AcceGen Basic Information, Manufacturing Base and Competitors
Table 137. AcceGen Major Business
Table 138. AcceGen iPSC-Derived Neural Progenitor Cells Product and Services
Table 139. AcceGen iPSC-Derived Neural Progenitor Cells Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 140. AcceGen Recent Developments/Updates
Table 141. AcceGen Competitive Strengths & Weaknesses
Table 142. Global Key Players of iPSC-Derived Neural Progenitor Cells Upstream (Raw Materials)
Table 143. Global iPSC-Derived Neural Progenitor Cells Typical Customers
Table 144. iPSC-Derived Neural Progenitor Cells Typical Distributors
Table 1. World iPSC-Derived Neural Progenitor Cells Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World iPSC-Derived Neural Progenitor Cells Production Value by Region (2021-2026) & (USD Million)
Table 3. World iPSC-Derived Neural Progenitor Cells Production Value by Region (2027-2032) & (USD Million)
Table 4. World iPSC-Derived Neural Progenitor Cells Production Value Market Share by Region (2021-2026)
Table 5. World iPSC-Derived Neural Progenitor Cells Production Value Market Share by Region (2027-2032)
Table 6. World iPSC-Derived Neural Progenitor Cells Production by Region (2021-2026) & (K Dose)
Table 7. World iPSC-Derived Neural Progenitor Cells Production by Region (2027-2032) & (K Dose)
Table 8. World iPSC-Derived Neural Progenitor Cells Production Market Share by Region (2021-2026)
Table 9. World iPSC-Derived Neural Progenitor Cells Production Market Share by Region (2027-2032)
Table 10. World iPSC-Derived Neural Progenitor Cells Average Price by Region (2021-2026) & (US$/Dose)
Table 11. World iPSC-Derived Neural Progenitor Cells Average Price by Region (2027-2032) & (US$/Dose)
Table 12. iPSC-Derived Neural Progenitor Cells Major Market Trends
Table 13. World iPSC-Derived Neural Progenitor Cells Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Dose)
Table 14. World iPSC-Derived Neural Progenitor Cells Consumption by Region (2021-2026) & (K Dose)
Table 15. World iPSC-Derived Neural Progenitor Cells Consumption Forecast by Region (2027-2032) & (K Dose)
Table 16. World iPSC-Derived Neural Progenitor Cells Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key iPSC-Derived Neural Progenitor Cells Producers in 2025
Table 18. World iPSC-Derived Neural Progenitor Cells Production by Manufacturer (2021-2026) & (K Dose)
Table 19. Production Market Share of Key iPSC-Derived Neural Progenitor Cells Producers in 2025
Table 20. World iPSC-Derived Neural Progenitor Cells Average Price by Manufacturer (2021-2026) & (US$/Dose)
Table 21. Global iPSC-Derived Neural Progenitor Cells Company Evaluation Quadrant
Table 22. World iPSC-Derived Neural Progenitor Cells Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and iPSC-Derived Neural Progenitor Cells Production Site of Key Manufacturer
Table 24. iPSC-Derived Neural Progenitor Cells Market: Company Product Type Footprint
Table 25. iPSC-Derived Neural Progenitor Cells Market: Company Product Application Footprint
Table 26. iPSC-Derived Neural Progenitor Cells Competitive Factors
Table 27. iPSC-Derived Neural Progenitor Cells New Entrant and Capacity Expansion Plans
Table 28. iPSC-Derived Neural Progenitor Cells Mergers & Acquisitions Activity
Table 29. United States VS China iPSC-Derived Neural Progenitor Cells Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China iPSC-Derived Neural Progenitor Cells Production Comparison, (2021 & 2025 & 2032) & (K Dose)
Table 31. United States VS China iPSC-Derived Neural Progenitor Cells Consumption Comparison, (2021 & 2025 & 2032) & (K Dose)
Table 32. United States Based iPSC-Derived Neural Progenitor Cells Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers iPSC-Derived Neural Progenitor Cells Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers iPSC-Derived Neural Progenitor Cells Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers iPSC-Derived Neural Progenitor Cells Production (2021-2026) & (K Dose)
Table 36. United States Based Manufacturers iPSC-Derived Neural Progenitor Cells Production Market Share (2021-2026)
Table 37. China Based iPSC-Derived Neural Progenitor Cells Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers iPSC-Derived Neural Progenitor Cells Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers iPSC-Derived Neural Progenitor Cells Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers iPSC-Derived Neural Progenitor Cells Production, (2021-2026) & (K Dose)
Table 41. China Based Manufacturers iPSC-Derived Neural Progenitor Cells Production Market Share (2021-2026)
Table 42. Rest of World Based iPSC-Derived Neural Progenitor Cells Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers iPSC-Derived Neural Progenitor Cells Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers iPSC-Derived Neural Progenitor Cells Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers iPSC-Derived Neural Progenitor Cells Production, (2021-2026) & (K Dose)
Table 46. Rest of World Based Manufacturers iPSC-Derived Neural Progenitor Cells Production Market Share (2021-2026)
Table 47. World iPSC-Derived Neural Progenitor Cells Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World iPSC-Derived Neural Progenitor Cells Production by Type (2021-2026) & (K Dose)
Table 49. World iPSC-Derived Neural Progenitor Cells Production by Type (2027-2032) & (K Dose)
Table 50. World iPSC-Derived Neural Progenitor Cells Production Value by Type (2021-2026) & (USD Million)
Table 51. World iPSC-Derived Neural Progenitor Cells Production Value by Type (2027-2032) & (USD Million)
Table 52. World iPSC-Derived Neural Progenitor Cells Average Price by Type (2021-2026) & (US$/Dose)
Table 53. World iPSC-Derived Neural Progenitor Cells Average Price by Type (2027-2032) & (US$/Dose)
Table 54. World iPSC-Derived Neural Progenitor Cells Production Value by Donor or Disease Background, (USD Million), 2021 & 2025 & 2032
Table 55. World iPSC-Derived Neural Progenitor Cells Production by Donor or Disease Background (2021-2026) & (K Dose)
Table 56. World iPSC-Derived Neural Progenitor Cells Production by Donor or Disease Background (2027-2032) & (K Dose)
Table 57. World iPSC-Derived Neural Progenitor Cells Production Value by Donor or Disease Background (2021-2026) & (USD Million)
Table 58. World iPSC-Derived Neural Progenitor Cells Production Value by Donor or Disease Background (2027-2032) & (USD Million)
Table 59. World iPSC-Derived Neural Progenitor Cells Average Price by Donor or Disease Background (2021-2026) & (US$/Dose)
Table 60. World iPSC-Derived Neural Progenitor Cells Average Price by Donor or Disease Background (2027-2032) & (US$/Dose)
Table 61. World iPSC-Derived Neural Progenitor Cells Production Value by Differentiation Stage, (USD Million), 2021 & 2025 & 2032
Table 62. World iPSC-Derived Neural Progenitor Cells Production by Differentiation Stage (2021-2026) & (K Dose)
Table 63. World iPSC-Derived Neural Progenitor Cells Production by Differentiation Stage (2027-2032) & (K Dose)
Table 64. World iPSC-Derived Neural Progenitor Cells Production Value by Differentiation Stage (2021-2026) & (USD Million)
Table 65. World iPSC-Derived Neural Progenitor Cells Production Value by Differentiation Stage (2027-2032) & (USD Million)
Table 66. World iPSC-Derived Neural Progenitor Cells Average Price by Differentiation Stage (2021-2026) & (US$/Dose)
Table 67. World iPSC-Derived Neural Progenitor Cells Average Price by Differentiation Stage (2027-2032) & (US$/Dose)
Table 68. World iPSC-Derived Neural Progenitor Cells Production Value by Quality Grade, (USD Million), 2021 & 2025 & 2032
Table 69. World iPSC-Derived Neural Progenitor Cells Production by Quality Grade (2021-2026) & (K Dose)
Table 70. World iPSC-Derived Neural Progenitor Cells Production by Quality Grade (2027-2032) & (K Dose)
Table 71. World iPSC-Derived Neural Progenitor Cells Production Value by Quality Grade (2021-2026) & (USD Million)
Table 72. World iPSC-Derived Neural Progenitor Cells Production Value by Quality Grade (2027-2032) & (USD Million)
Table 73. World iPSC-Derived Neural Progenitor Cells Average Price by Quality Grade (2021-2026) & (US$/Dose)
Table 74. World iPSC-Derived Neural Progenitor Cells Average Price by Quality Grade (2027-2032) & (US$/Dose)
Table 75. World iPSC-Derived Neural Progenitor Cells Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 76. World iPSC-Derived Neural Progenitor Cells Production by Application (2021-2026) & (K Dose)
Table 77. World iPSC-Derived Neural Progenitor Cells Production by Application (2027-2032) & (K Dose)
Table 78. World iPSC-Derived Neural Progenitor Cells Production Value by Application (2021-2026) & (USD Million)
Table 79. World iPSC-Derived Neural Progenitor Cells Production Value by Application (2027-2032) & (USD Million)
Table 80. World iPSC-Derived Neural Progenitor Cells Average Price by Application (2021-2026) & (US$/Dose)
Table 81. World iPSC-Derived Neural Progenitor Cells Average Price by Application (2027-2032) & (US$/Dose)
Table 82. STEMCELL Technologies Basic Information, Manufacturing Base and Competitors
Table 83. STEMCELL Technologies Major Business
Table 84. STEMCELL Technologies iPSC-Derived Neural Progenitor Cells Product and Services
Table 85. STEMCELL Technologies iPSC-Derived Neural Progenitor Cells Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 86. STEMCELL Technologies Recent Developments/Updates
Table 87. STEMCELL Technologies Competitive Strengths & Weaknesses
Table 88. Merck Basic Information, Manufacturing Base and Competitors
Table 89. Merck Major Business
Table 90. Merck iPSC-Derived Neural Progenitor Cells Product and Services
Table 91. Merck iPSC-Derived Neural Progenitor Cells Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 92. Merck Recent Developments/Updates
Table 93. Merck Competitive Strengths & Weaknesses
Table 94. Applied StemCell Basic Information, Manufacturing Base and Competitors
Table 95. Applied StemCell Major Business
Table 96. Applied StemCell iPSC-Derived Neural Progenitor Cells Product and Services
Table 97. Applied StemCell iPSC-Derived Neural Progenitor Cells Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 98. Applied StemCell Recent Developments/Updates
Table 99. Applied StemCell Competitive Strengths & Weaknesses
Table 100. Axol Bioscience Basic Information, Manufacturing Base and Competitors
Table 101. Axol Bioscience Major Business
Table 102. Axol Bioscience iPSC-Derived Neural Progenitor Cells Product and Services
Table 103. Axol Bioscience iPSC-Derived Neural Progenitor Cells Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 104. Axol Bioscience Recent Developments/Updates
Table 105. Axol Bioscience Competitive Strengths & Weaknesses
Table 106. Tempo Bioscience Basic Information, Manufacturing Base and Competitors
Table 107. Tempo Bioscience Major Business
Table 108. Tempo Bioscience iPSC-Derived Neural Progenitor Cells Product and Services
Table 109. Tempo Bioscience iPSC-Derived Neural Progenitor Cells Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 110. Tempo Bioscience Recent Developments/Updates
Table 111. Tempo Bioscience Competitive Strengths & Weaknesses
Table 112. Creative Bioarray Basic Information, Manufacturing Base and Competitors
Table 113. Creative Bioarray Major Business
Table 114. Creative Bioarray iPSC-Derived Neural Progenitor Cells Product and Services
Table 115. Creative Bioarray iPSC-Derived Neural Progenitor Cells Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 116. Creative Bioarray Recent Developments/Updates
Table 117. Creative Bioarray Competitive Strengths & Weaknesses
Table 118. ACROBiosystems Basic Information, Manufacturing Base and Competitors
Table 119. ACROBiosystems Major Business
Table 120. ACROBiosystems iPSC-Derived Neural Progenitor Cells Product and Services
Table 121. ACROBiosystems iPSC-Derived Neural Progenitor Cells Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 122. ACROBiosystems Recent Developments/Updates
Table 123. ACROBiosystems Competitive Strengths & Weaknesses
Table 124. ATCC Basic Information, Manufacturing Base and Competitors
Table 125. ATCC Major Business
Table 126. ATCC iPSC-Derived Neural Progenitor Cells Product and Services
Table 127. ATCC iPSC-Derived Neural Progenitor Cells Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 128. ATCC Recent Developments/Updates
Table 129. ATCC Competitive Strengths & Weaknesses
Table 130. Cell Applications Basic Information, Manufacturing Base and Competitors
Table 131. Cell Applications Major Business
Table 132. Cell Applications iPSC-Derived Neural Progenitor Cells Product and Services
Table 133. Cell Applications iPSC-Derived Neural Progenitor Cells Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 134. Cell Applications Recent Developments/Updates
Table 135. Cell Applications Competitive Strengths & Weaknesses
Table 136. AcceGen Basic Information, Manufacturing Base and Competitors
Table 137. AcceGen Major Business
Table 138. AcceGen iPSC-Derived Neural Progenitor Cells Product and Services
Table 139. AcceGen iPSC-Derived Neural Progenitor Cells Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 140. AcceGen Recent Developments/Updates
Table 141. AcceGen Competitive Strengths & Weaknesses
Table 142. Global Key Players of iPSC-Derived Neural Progenitor Cells Upstream (Raw Materials)
Table 143. Global iPSC-Derived Neural Progenitor Cells Typical Customers
Table 144. iPSC-Derived Neural Progenitor Cells Typical Distributors
LIST OF FIGURES
Figure 1. iPSC-Derived Neural Progenitor Cells Picture
Figure 2. World iPSC-Derived Neural Progenitor Cells Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World iPSC-Derived Neural Progenitor Cells Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World iPSC-Derived Neural Progenitor Cells Production (2021-2032) & (K Dose)
Figure 5. World iPSC-Derived Neural Progenitor Cells Average Price (2021-2032) & (US$/Dose)
Figure 6. World iPSC-Derived Neural Progenitor Cells Production Value Market Share by Region (2021-2032)
Figure 7. World iPSC-Derived Neural Progenitor Cells Production Market Share by Region (2021-2032)
Figure 8. North America iPSC-Derived Neural Progenitor Cells Production (2021-2032) & (K Dose)
Figure 9. Europe iPSC-Derived Neural Progenitor Cells Production (2021-2032) & (K Dose)
Figure 10. China iPSC-Derived Neural Progenitor Cells Production (2021-2032) & (K Dose)
Figure 11. Japan iPSC-Derived Neural Progenitor Cells Production (2021-2032) & (K Dose)
Figure 12. India iPSC-Derived Neural Progenitor Cells Production (2021-2032) & (K Dose)
Figure 13. India iPSC-Derived Neural Progenitor Cells Production (2021-2032) & (K Dose)
Figure 14. South America iPSC-Derived Neural Progenitor Cells Production (2021-2032) & (K Dose)
Figure 15. Middle East iPSC-Derived Neural Progenitor Cells Production (2021-2032) & (K Dose)
Figure 16. iPSC-Derived Neural Progenitor Cells Market Drivers
Figure 17. Factors Affecting Demand
Figure 18. World iPSC-Derived Neural Progenitor Cells Consumption (2021-2032) & (K Dose)
Figure 19. World iPSC-Derived Neural Progenitor Cells Consumption Market Share by Region (2021-2032)
Figure 20. United States iPSC-Derived Neural Progenitor Cells Consumption (2021-2032) & (K Dose)
Figure 21. China iPSC-Derived Neural Progenitor Cells Consumption (2021-2032) & (K Dose)
Figure 22. Europe iPSC-Derived Neural Progenitor Cells Consumption (2021-2032) & (K Dose)
Figure 23. Japan iPSC-Derived Neural Progenitor Cells Consumption (2021-2032) & (K Dose)
Figure 24. South Korea iPSC-Derived Neural Progenitor Cells Consumption (2021-2032) & (K Dose)
Figure 25. ASEAN iPSC-Derived Neural Progenitor Cells Consumption (2021-2032) & (K Dose)
Figure 26. India iPSC-Derived Neural Progenitor Cells Consumption (2021-2032) & (K Dose)
Figure 27. Producer Shipments of iPSC-Derived Neural Progenitor Cells by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 28. Global Four-firm Concentration Ratios (CR4) for iPSC-Derived Neural Progenitor Cells Markets in 2025
Figure 29. Global Four-firm Concentration Ratios (CR8) for iPSC-Derived Neural Progenitor Cells Markets in 2025
Figure 30. United States VS China: iPSC-Derived Neural Progenitor Cells Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 31. United States VS China: iPSC-Derived Neural Progenitor Cells Production Market Share Comparison (2021 & 2025 & 2032)
Figure 32. United States VS China: iPSC-Derived Neural Progenitor Cells Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 33. United States Based Manufacturers iPSC-Derived Neural Progenitor Cells Production Market Share 2025
Figure 34. China Based Manufacturers iPSC-Derived Neural Progenitor Cells Production Market Share 2025
Figure 35. Rest of World Based Manufacturers iPSC-Derived Neural Progenitor Cells Production Market Share 2025
Figure 36. World iPSC-Derived Neural Progenitor Cells Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 37. World iPSC-Derived Neural Progenitor Cells Production Value Market Share by Type in 2025
Figure 38. Cryopreserved Cells
Figure 39. Cell and Media Kits
Figure 40. Differentiation Kits
Figure 41. Disease-Specific Cells
Figure 42. Custom or GMP-Compatible Cells
Figure 43. Other Formats
Figure 44. World iPSC-Derived Neural Progenitor Cells Production Market Share by Type (2021-2032)
Figure 45. World iPSC-Derived Neural Progenitor Cells Production Value Market Share by Type (2021-2032)
Figure 46. World iPSC-Derived Neural Progenitor Cells Average Price by Type (2021-2032) & (US$/Dose)
Figure 47. World iPSC-Derived Neural Progenitor Cells Production Value by Donor or Disease Background, (USD Million), 2021 & 2025 & 2032
Figure 48. World iPSC-Derived Neural Progenitor Cells Production Value Market Share by Donor or Disease Background in 2025
Figure 49. Healthy Control Donor
Figure 50. Patient-Derived Disease Model
Figure 51. Gene-Edited Reporter Line
Figure 52. Immune-Matched or HLA Line
Figure 53. Custom Donor Background
Figure 54. Other Donor Background
Figure 55. World iPSC-Derived Neural Progenitor Cells Production Market Share by Donor or Disease Background (2021-2032)
Figure 56. World iPSC-Derived Neural Progenitor Cells Production Value Market Share by Donor or Disease Background (2021-2032)
Figure 57. World iPSC-Derived Neural Progenitor Cells Average Price by Donor or Disease Background (2021-2032) & (US$/Dose)
Figure 58. World iPSC-Derived Neural Progenitor Cells Production Value by Differentiation Stage, (USD Million), 2021 & 2025 & 2032
Figure 59. World iPSC-Derived Neural Progenitor Cells Production Value Market Share by Differentiation Stage in 2025
Figure 60. Neural Stem Cells
Figure 61. Neural Progenitor Cells
Figure 62. Regional Neural Progenitors
Figure 63. Lineage-Committed Progenitors
Figure 64. Mature Neural Derivatives
Figure 65. Other Differentiation Stages
Figure 66. World iPSC-Derived Neural Progenitor Cells Production Market Share by Differentiation Stage (2021-2032)
Figure 67. World iPSC-Derived Neural Progenitor Cells Production Value Market Share by Differentiation Stage (2021-2032)
Figure 68. World iPSC-Derived Neural Progenitor Cells Average Price by Differentiation Stage (2021-2032) & (US$/Dose)
Figure 69. World iPSC-Derived Neural Progenitor Cells Production Value by Quality Grade, (USD Million), 2021 & 2025 & 2032
Figure 70. World iPSC-Derived Neural Progenitor Cells Production Value Market Share by Quality Grade in 2025
Figure 71. Research Use Only Grade
Figure 72. Assay-Ready Grade
Figure 73. Xeno-Free Defined Grade
Figure 74. GMP-Compatible Grade
Figure 75. Custom Validated Grade
Figure 76. Other Quality Grades
Figure 77. World iPSC-Derived Neural Progenitor Cells Production Market Share by Quality Grade (2021-2032)
Figure 78. World iPSC-Derived Neural Progenitor Cells Production Value Market Share by Quality Grade (2021-2032)
Figure 79. World iPSC-Derived Neural Progenitor Cells Average Price by Quality Grade (2021-2032) & (US$/Dose)
Figure 80. World iPSC-Derived Neural Progenitor Cells Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 81. World iPSC-Derived Neural Progenitor Cells Production Value Market Share by Application in 2025
Figure 82. Neurological Disease Modeling
Figure 83. Neurotoxicity and Safety Testing
Figure 84. Drug Screening and Target Validation
Figure 85. Neural Differentiation and Organoid Culture
Figure 86. Regenerative Medicine Research
Figure 87. Other Applications
Figure 88. World iPSC-Derived Neural Progenitor Cells Production Market Share by Application (2021-2032)
Figure 89. World iPSC-Derived Neural Progenitor Cells Production Value Market Share by Application (2021-2032)
Figure 90. World iPSC-Derived Neural Progenitor Cells Average Price by Application (2021-2032) & (US$/Dose)
Figure 91. iPSC-Derived Neural Progenitor Cells Industry Chain
Figure 92. iPSC-Derived Neural Progenitor Cells Procurement Model
Figure 93. iPSC-Derived Neural Progenitor Cells Sales Model
Figure 94. iPSC-Derived Neural Progenitor Cells Sales Channels, Direct Sales, and Distribution
Figure 95. Methodology
Figure 96. Research Process and Data Source
Figure 1. iPSC-Derived Neural Progenitor Cells Picture
Figure 2. World iPSC-Derived Neural Progenitor Cells Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World iPSC-Derived Neural Progenitor Cells Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World iPSC-Derived Neural Progenitor Cells Production (2021-2032) & (K Dose)
Figure 5. World iPSC-Derived Neural Progenitor Cells Average Price (2021-2032) & (US$/Dose)
Figure 6. World iPSC-Derived Neural Progenitor Cells Production Value Market Share by Region (2021-2032)
Figure 7. World iPSC-Derived Neural Progenitor Cells Production Market Share by Region (2021-2032)
Figure 8. North America iPSC-Derived Neural Progenitor Cells Production (2021-2032) & (K Dose)
Figure 9. Europe iPSC-Derived Neural Progenitor Cells Production (2021-2032) & (K Dose)
Figure 10. China iPSC-Derived Neural Progenitor Cells Production (2021-2032) & (K Dose)
Figure 11. Japan iPSC-Derived Neural Progenitor Cells Production (2021-2032) & (K Dose)
Figure 12. India iPSC-Derived Neural Progenitor Cells Production (2021-2032) & (K Dose)
Figure 13. India iPSC-Derived Neural Progenitor Cells Production (2021-2032) & (K Dose)
Figure 14. South America iPSC-Derived Neural Progenitor Cells Production (2021-2032) & (K Dose)
Figure 15. Middle East iPSC-Derived Neural Progenitor Cells Production (2021-2032) & (K Dose)
Figure 16. iPSC-Derived Neural Progenitor Cells Market Drivers
Figure 17. Factors Affecting Demand
Figure 18. World iPSC-Derived Neural Progenitor Cells Consumption (2021-2032) & (K Dose)
Figure 19. World iPSC-Derived Neural Progenitor Cells Consumption Market Share by Region (2021-2032)
Figure 20. United States iPSC-Derived Neural Progenitor Cells Consumption (2021-2032) & (K Dose)
Figure 21. China iPSC-Derived Neural Progenitor Cells Consumption (2021-2032) & (K Dose)
Figure 22. Europe iPSC-Derived Neural Progenitor Cells Consumption (2021-2032) & (K Dose)
Figure 23. Japan iPSC-Derived Neural Progenitor Cells Consumption (2021-2032) & (K Dose)
Figure 24. South Korea iPSC-Derived Neural Progenitor Cells Consumption (2021-2032) & (K Dose)
Figure 25. ASEAN iPSC-Derived Neural Progenitor Cells Consumption (2021-2032) & (K Dose)
Figure 26. India iPSC-Derived Neural Progenitor Cells Consumption (2021-2032) & (K Dose)
Figure 27. Producer Shipments of iPSC-Derived Neural Progenitor Cells by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 28. Global Four-firm Concentration Ratios (CR4) for iPSC-Derived Neural Progenitor Cells Markets in 2025
Figure 29. Global Four-firm Concentration Ratios (CR8) for iPSC-Derived Neural Progenitor Cells Markets in 2025
Figure 30. United States VS China: iPSC-Derived Neural Progenitor Cells Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 31. United States VS China: iPSC-Derived Neural Progenitor Cells Production Market Share Comparison (2021 & 2025 & 2032)
Figure 32. United States VS China: iPSC-Derived Neural Progenitor Cells Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 33. United States Based Manufacturers iPSC-Derived Neural Progenitor Cells Production Market Share 2025
Figure 34. China Based Manufacturers iPSC-Derived Neural Progenitor Cells Production Market Share 2025
Figure 35. Rest of World Based Manufacturers iPSC-Derived Neural Progenitor Cells Production Market Share 2025
Figure 36. World iPSC-Derived Neural Progenitor Cells Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 37. World iPSC-Derived Neural Progenitor Cells Production Value Market Share by Type in 2025
Figure 38. Cryopreserved Cells
Figure 39. Cell and Media Kits
Figure 40. Differentiation Kits
Figure 41. Disease-Specific Cells
Figure 42. Custom or GMP-Compatible Cells
Figure 43. Other Formats
Figure 44. World iPSC-Derived Neural Progenitor Cells Production Market Share by Type (2021-2032)
Figure 45. World iPSC-Derived Neural Progenitor Cells Production Value Market Share by Type (2021-2032)
Figure 46. World iPSC-Derived Neural Progenitor Cells Average Price by Type (2021-2032) & (US$/Dose)
Figure 47. World iPSC-Derived Neural Progenitor Cells Production Value by Donor or Disease Background, (USD Million), 2021 & 2025 & 2032
Figure 48. World iPSC-Derived Neural Progenitor Cells Production Value Market Share by Donor or Disease Background in 2025
Figure 49. Healthy Control Donor
Figure 50. Patient-Derived Disease Model
Figure 51. Gene-Edited Reporter Line
Figure 52. Immune-Matched or HLA Line
Figure 53. Custom Donor Background
Figure 54. Other Donor Background
Figure 55. World iPSC-Derived Neural Progenitor Cells Production Market Share by Donor or Disease Background (2021-2032)
Figure 56. World iPSC-Derived Neural Progenitor Cells Production Value Market Share by Donor or Disease Background (2021-2032)
Figure 57. World iPSC-Derived Neural Progenitor Cells Average Price by Donor or Disease Background (2021-2032) & (US$/Dose)
Figure 58. World iPSC-Derived Neural Progenitor Cells Production Value by Differentiation Stage, (USD Million), 2021 & 2025 & 2032
Figure 59. World iPSC-Derived Neural Progenitor Cells Production Value Market Share by Differentiation Stage in 2025
Figure 60. Neural Stem Cells
Figure 61. Neural Progenitor Cells
Figure 62. Regional Neural Progenitors
Figure 63. Lineage-Committed Progenitors
Figure 64. Mature Neural Derivatives
Figure 65. Other Differentiation Stages
Figure 66. World iPSC-Derived Neural Progenitor Cells Production Market Share by Differentiation Stage (2021-2032)
Figure 67. World iPSC-Derived Neural Progenitor Cells Production Value Market Share by Differentiation Stage (2021-2032)
Figure 68. World iPSC-Derived Neural Progenitor Cells Average Price by Differentiation Stage (2021-2032) & (US$/Dose)
Figure 69. World iPSC-Derived Neural Progenitor Cells Production Value by Quality Grade, (USD Million), 2021 & 2025 & 2032
Figure 70. World iPSC-Derived Neural Progenitor Cells Production Value Market Share by Quality Grade in 2025
Figure 71. Research Use Only Grade
Figure 72. Assay-Ready Grade
Figure 73. Xeno-Free Defined Grade
Figure 74. GMP-Compatible Grade
Figure 75. Custom Validated Grade
Figure 76. Other Quality Grades
Figure 77. World iPSC-Derived Neural Progenitor Cells Production Market Share by Quality Grade (2021-2032)
Figure 78. World iPSC-Derived Neural Progenitor Cells Production Value Market Share by Quality Grade (2021-2032)
Figure 79. World iPSC-Derived Neural Progenitor Cells Average Price by Quality Grade (2021-2032) & (US$/Dose)
Figure 80. World iPSC-Derived Neural Progenitor Cells Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 81. World iPSC-Derived Neural Progenitor Cells Production Value Market Share by Application in 2025
Figure 82. Neurological Disease Modeling
Figure 83. Neurotoxicity and Safety Testing
Figure 84. Drug Screening and Target Validation
Figure 85. Neural Differentiation and Organoid Culture
Figure 86. Regenerative Medicine Research
Figure 87. Other Applications
Figure 88. World iPSC-Derived Neural Progenitor Cells Production Market Share by Application (2021-2032)
Figure 89. World iPSC-Derived Neural Progenitor Cells Production Value Market Share by Application (2021-2032)
Figure 90. World iPSC-Derived Neural Progenitor Cells Average Price by Application (2021-2032) & (US$/Dose)
Figure 91. iPSC-Derived Neural Progenitor Cells Industry Chain
Figure 92. iPSC-Derived Neural Progenitor Cells Procurement Model
Figure 93. iPSC-Derived Neural Progenitor Cells Sales Model
Figure 94. iPSC-Derived Neural Progenitor Cells Sales Channels, Direct Sales, and Distribution
Figure 95. Methodology
Figure 96. Research Process and Data Source
